Press release
Eosinophilic Disorders Market is Rising with Biologic Drug Approvals and Increasing Autoimmune Cases|Key Players: Novartis A.G, GlaxoSmithKline Plc., Teva Pharmaceutical, Pfizer Inc., AstraZeneca, Sanofi S.A
Eosinophilic Disorders Market
The latest Eosinophilic Disorders Market Report by DataM Intelligence offers a clear analysis of global trends, market size, key players, and growth drivers. Covering emerging technologies, evolving care models, and regulatory insights, it provides strategic intelligence to help stakeholders navigate the dynamic healthcare landscape through 2025-2033
Download exclusive insights with our detailed sample report (Corporate Email ID gets priority access):
https://www.datamintelligence.com/download-sample/eosinophilic-disorders-market?ophp
Eosinophilic disorders involve abnormal accumulation of eosinophils, leading to inflammation and tissue damage in organs such as the lungs, skin, and gastrointestinal tract. The market is expanding due to increasing prevalence, improved diagnostic capabilities, and development of targeted biologic therapies like IL-5 and IL-13 inhibitors.
Eosinophilic Disorders Market Competitors Overview:
Novartis A.G, GlaxoSmithKline Plc., Teva Pharmaceutical, Pfizer Inc., AstraZeneca, Sanofi S.A, Curia, LGM Pharma, Henan Lihua Pharmaceuticals Ltd., and Hikma Pharmaceuticals among others.
Important Industry Updates of 2024 and 2025:
1. On March 24, 2025, the European Medicines Agency accepted GSK's application to expand Nucala (mepolizumab) to treat eosinophilic COPD, following trials demonstrating a reduction in exacerbations compared to placebo.
2. On May 7, 2025, the FDA's Prescription Drug User Fee Act (PDUFA) date was set for the regulatory review of mepolizumab as an add-on therapy for eosinophilic COPD patients.
3. On May 22, 2025, the FDA officially approved Nucala as an add-on maintenance treatment for adult patients with eosinophilic COPD.
4. On April 21, 2025, the FDA granted Orphan Drug Designation to NS 229, a selective JAK1 inhibitor, for the treatment of eosinophilic granulomatosis with polyangiitis (EGPA).
5. In January 2025, a meta-analysis confirmed the FDA approval of benralizumab (Fasenra) in September 2024 for EGPA, highlighting its steroid-sparing effects and strong remission rates.
Eosinophilic Disorders Market Segments Overview:
∎ By Type (Eosinophilic Esophagitis, Eosinophilic Gastritis, Eosinophilic Enteritis, Eosinophilic Colitis, Hypereosinophilic Syndrome)
∎ By Treatment (Medications, Dietary Therapy, Dilation, Others)
∎ By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others)
Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/eosinophilic-disorders-market?ophp
Methodology and Scope:
This Eosinophilic Disorders Market report is developed using a robust research methodology that combines primary interviews, insights from industry experts, and verified secondary sources such as company filings, trade journals, and trusted databases. It follows a bottom-up and top-down approach to ensure data accuracy through triangulation. The scope of the report covers current market trends, growth potential, and strategic developments across global and regional markets.
Regional Overview for Eosinophilic Disorders Market:
⇥ North America (U.S., Canada, Mexico)
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
Looking For Exclusive Full Report? Get it here: https://www.datamintelligence.com/buy-now-page?report=eosinophilic-disorders-market?ophp
The Report Includes:
➡ A descriptive analysis of demand-supply gap, market size estimation, SWOT analysis, PESTEL Analysis and forecast in the global market.
➡ Go-to-market Strategy.
➡ Neutral perspective on the market performance.
➡ Customized regional/country reports as per request and country level analysis.
➡ Potential & niche segments and regions exhibiting promising growth covered.
People Also Ask:
➤ What are the global sales, production, import, and export trends in the Eosinophilic Disorders market?
➤ Who are the top manufacturers, and what are their output, pricing, and revenue figures?
➤ What key opportunities and challenges do vendors face in this market?
➤ Which product types, applications, or end-users are driving growth and holding market share?
➤ What are the main growth drivers and restraints affecting the Eosinophilic Disorders market?
Unlock 360° Market Intelligence with DataM Subscription Services:
https://www.datamintelligence.com/reports-subscription
✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Pipeline Analysis For Drugs Discovery
✅ Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Competitive Landscape
Have a look at our Subscription Dashboard:
https://www.youtube.com/watch?v=x5oEiqEqTWg
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Eosinophilic Disorders Market is Rising with Biologic Drug Approvals and Increasing Autoimmune Cases|Key Players: Novartis A.G, GlaxoSmithKline Plc., Teva Pharmaceutical, Pfizer Inc., AstraZeneca, Sanofi S.A here
News-ID: 4104933 • Views: …
More Releases from DataM intelligence 4 Market Research LLP
Renewable Energy Storage Market to Reach $2.25 Bn by 2031, CAGR 11.4% (2024-2031 …
Global Renewable Energy Storage Market reached US$ 949.9 Million in 2023 and is expected to reach US$ 2,253.0 Million by 2031, growing with a CAGR of 11.4% during the forecast period 2024-2031.
The global Renewable Energy Storage market has witnessed significant growth over the past few years, driven by increasing demand across multiple industries and advancements in technology. The market is characterized by rising adoption of innovative solutions, growing consumer awareness,…
Agrivoltaics Market to Hit USD 8.41 Bn by 2032, CAGR 8.68% (2025-2032) Driven by …
Global Agrivoltaics Market reached US$ 4.32 billion in 2024 and is expected to reach US$ 8.41 billion by 2032, growing with a CAGR of 8.68% during the forecast period 2025-2032, according to DataM Intelligence report.
The global Agrivoltaics market has witnessed significant growth over the past few years, driven by increasing demand across multiple industries and advancements in technology. The market is characterized by rising adoption of innovative solutions, growing consumer…
Styrene Market Attracts Investment as Manufacturers Focus on Bio-Based & Sustain …
"The Global Styrene market to grow at a CAGR Of 5% during the forecast period 2024- 2031." As per DataM intelligence research report
The Styrene Market report by DataM Intelligence provides comprehensive insights and analysis on key market trends, growth opportunities, and emerging challenges. With a commitment to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead of the competition. By combining qualitative and quantitative…
Electric Cargo Bikes Market Booming, Attracts Investments in Green Transportatio …
"The global electric cargo bikes market reached USD 940.24 million in 2022 and is projected to witness lucrative growth by reaching up to USD 3,659.2 million by 2031. The market is expected to exhibit a CAGR of 17.0% during the forecast period (2024-2031)." As per DataM intelligence research report
The Electric Cargo Bikes Market report by DataM Intelligence provides comprehensive insights and analysis on key market trends, growth opportunities, and emerging…
More Releases for Eosinophilic
Eosinophilic Esophagitis Market to Surge to USD 4.1 Billion by 2034
Eosinophilic Esophagitis (EoE) is a chronic, immune-mediated inflammatory condition of the esophagus, characterized by eosinophil infiltration, difficulty swallowing, food impaction, and chest pain. Once considered rare, EoE has now emerged as one of the most common causes of dysphagia in children and adults, particularly in developed nations. Strong associations with allergic conditions such as asthma, eczema, and food allergies underscore its complex immunological nature.
Download Full PDF Sample Copy of Market…
Eosinophilic Asthma Treatment Market Outlook and Future Projections for 2030
The eosinophilic asthma treatment market represents a dynamic and continually evolving landscape, shaped by changing consumer demands and technological advancements. In this comprehensive report, we provide an in-depth exploration of the market, designed for a wide range of stakeholders including manufacturers, suppliers, distributors, and investors. Our goal is to equip industry participants with essential insights that enable informed decision-making in an ever-changing market environment. This analysis not only examines the…
Severe Eosinophilic Asthma Treatment Market Outlook and Future Projections for 2 …
The severe eosinophilic asthma treatment market represents a dynamic and continually evolving landscape, shaped by changing consumer demands and technological advancements. In this comprehensive report, we provide an in-depth exploration of the market, designed for a wide range of stakeholders including manufacturers, suppliers, distributors, and investors. Our goal is to equip industry participants with essential insights that enable informed decision-making in an ever-changing market environment. This analysis not only examines…
Eosinophilic Esophagitis Pipeline, Clinical Trials Assessment, Emerging Therapie …
DelveInsight's, "Eosinophilic Esophagitis Pipeline Insight" report provides comprehensive insights about 25+ companies and 30+ pipeline drugs in Eosinophilic Esophagitis pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore our latest breakthroughs in Eosinophilic Esophagitis research. Learn more about…
Severe Eosinophilic Asthma Treatment Market Outlook and Future Projections for 2 …
The severe eosinophilic asthma treatment market represents a dynamic and continually evolving landscape, shaped by changing consumer demands and technological advancements. In this comprehensive report, we provide an in-depth exploration of the market, designed for a wide range of stakeholders including manufacturers, suppliers, distributors, and investors. Our goal is to equip industry participants with essential insights that enable informed decision-making in an ever-changing market environment. This analysis not only examines…
Eosinophilic Granulomatosis Treatment Market Size and Overview Upto 2028|
The report comes out as an intelligent and thorough assessment tool as well as a great resource that will help you to secure a position of strength in the global Eosinophilic Granulomatosis Treatment market. It includes Porter's Five Forces and PESTLE analysis to equip your business with critical information and comparative data about the Global Eosinophilic Granulomatosis Treatment Market. We have provided a deep analysis of the vendor landscape to give…
